Menu

Endocannabinoids in the Groove

The system responsible for the buzz humans get from marijuana plays a passel of physiological roles outside the brain.

Jul 16, 2017
Megan Scudellari

ENDOCANNABINOID SIGNALING IN THE BODY

The two classical cannabinoid receptors, CB1 and CB2, are expressed by enteric neurons, immune cells, and other cell types within the gastrointestinal tract. The gut and the liver also synthesize two key ligands—anandamide (AEA) and 2-arachidonoylglycerol (2-AG)—for those receptors. Combined, this signaling system acts locally in the gut and liver, but also communicates with the brain to affect food intake, pain, inflammation, and more.

© PENS AND BEETLES STUDIOS

In the liver, endocannabinoids are thought to act almost like hormones, stimulating cell division at some times, cell death at others. In the healthy liver, expression of CB receptors is very low, but in a diseased liver expression increases, and endocannabinoid ligands are released from all four cell types shown here. Many ligands are produced and bind to CB1 receptors, causing lipid accumulation and insulin resistance in hepatocytes, and increased proliferation of activated stellate cells, the major cell type involved in fibrosis (scarring) of the liver. Blocking CB1 receptors with drugs decreased the amount of fibrosis in mouse models.

© PENS AND BEETLES STUDIOSBoth CB1 and CB2 regulate the rhythmic contractions of the intestinal tract, called gut motility. In the healthy gut, CB1 predominates, but during intestinal inflammation, CB2 also contributes to motility. Conditions such as inflammatory bowel disease and celiac disease often exhibit increased prevalence of these receptors, which results in decreased motility. Endocannabinoid signaling has also been shown to reduce inflammation, increase the permeability of gut epithelial cells, and signal hunger to the brain.

Read the full story.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.